Loading…
Lobbying Spend
—
Filings
22
Firms Hired
1
Active Period
2021–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · fourth_quarter · Firm: ML STRATEGIES, LLC
Issues related to the medical device industry in New England, including: workforce development, H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
2025 · third_quarter · Firm: ML STRATEGIES, LLC
Issues related to the medical device industry in New England, including: workforce development, APRA-H Investment Catalyst Hub establishment, EtO regulation, Transitional Coverage of Emerging Technologies notice, and H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2025 · second_quarter · Firm: ML STRATEGIES, LLC
Issues related to the medical device industry in New England, including: workforce development, APRA-H Investment Catalyst Hub establishment, EtO regulation, Transitional Coverage of Emerging Technologies notice, and H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2025 · first_quarter · Firm: ML STRATEGIES, LLC
Issues related to the medical device industry in New England, including: workforce development, APRA-H Investment Catalyst Hub establishment, EtO regulation, Transitional Coverage of Emerging Technologies notice, and H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · fourth_quarter · Firm: ML STRATEGIES, LLC
Issues related to the medical device industry in New England, including: workforce development, APRA-H Investment Catalyst Hub establishment, EtO regulation, Transitional Coverage of Emerging Technologies notice, and H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · third_quarter · Firm: ML STRATEGIES, LLC
Issues related to the medical device industry in New England, including: workforce development, APRA-H Investment Catalyst Hub establishment, EtO regulation, Transitional Coverage of Emerging Technologies notice, and H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · second_quarter · Firm: ML STRATEGIES, LLC
Issues related to the medical device industry in New England, including: workforce development, APRA-H Investment Catalyst Hub establishment, EtO regulation, Transitional Coverage of Emerging Technologies notice, and H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · first_quarter · Firm: ML STRATEGIES, LLC
Issues related to the medical device industry in New England, including: workforce development, APRA-H Investment Catalyst Hub establishment, EtO regulation, Transitional Coverage of Emerging Technologies notice, and H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2023 · fourth_quarter · Firm: ML STRATEGIES, LLC
Issues related to the medical device industry in New England, including: workforce development, APRA-H Investment Catalyst Hub establishment, EtO regulation, Transitional Coverage of Emerging Technologies notice, and H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2023 · third_quarter · Firm: ML STRATEGIES, LLC
Issues related to medical device industry, semiconductor shortage, workforce developement; ARPA-H Investor Catalyst Hub selection, EtO regulation, HR 1691 Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: — · Firm income: $20,000
Matched citations: HR 1691
Source: Senate LDA